Multisystem inflammatory syndrome in adults following COVID-19 infection: A case report presenting with colitis.
COVID-19
Colitis
Immunoglobulin
Multisystem inflammatory syndrome in adults
Severe acute respiratory syndrome coronavirus 2
Journal
Clinical infection in practice
ISSN: 2590-1702
Titre abrégé: Clin Infect Pract
Pays: England
ID NLM: 101757436
Informations de publication
Date de publication:
Nov 2021
Nov 2021
Historique:
received:
30
03
2021
revised:
18
06
2021
accepted:
17
08
2021
entrez:
30
8
2021
pubmed:
31
8
2021
medline:
31
8
2021
Statut:
ppublish
Résumé
Multisystem Inflammatory Syndrome in Adults (MIS-A) is a recently emerging condition that occurs as a delayed complication of COVID-19 infection. It involves inflammation of multiple extra-pulmonary organ systems. Diagnostic criteria and treatment recommendations have yet to be clearly defined. We present a case of a young adult with suspected MIS-A who initially displayed symptoms and radiological findings of colitis.Case: A 22-year-old male with no past medical history suffered a minor respiratory illness for a few days and tested positive on SARS-CoV-2 RT-PCR. Approximately 6 weeks later, he presents after 3 days of right-sided abdominal pain, diarrhoea and fever. He is initially admitted with a working diagnosis of gastroenteritis. Sustained fever and escalating blood markers of illness led to abdominal CT; showing inflammation of ascending colon as well as some loops of small bowel. Hypotension becomes increasingly pronounced and on the fourth day of admission he developed type 1 respiratory failure with evidence of fluid overload. He was transferred to critical care for vasopressor and respiratory support. All microbiological and autoimmune screens performed return negative results but inflammatory markers were significantly elevated, he was diagnosed as MIS-A. IVIg was added to the antibiotics on day 4. His clinical condition dramatically improved and he was discharged home after 10 days in hospital. His blood tests have returned to normal and he has no lasting complications from his illness. This case displays the potential for MIS-A to present in various ways, with this example a primarily gastroenterological illness. It therefore highlights the importance of physicians in different fields having an awareness of the condition, in order to identify when MDT input is required to guide treatment. We review the current literature on various presentations and treatments of MIS-A, and discuss the need for clear case definition.
Sections du résumé
BACKGROUND
BACKGROUND
Multisystem Inflammatory Syndrome in Adults (MIS-A) is a recently emerging condition that occurs as a delayed complication of COVID-19 infection. It involves inflammation of multiple extra-pulmonary organ systems. Diagnostic criteria and treatment recommendations have yet to be clearly defined. We present a case of a young adult with suspected MIS-A who initially displayed symptoms and radiological findings of colitis.Case: A 22-year-old male with no past medical history suffered a minor respiratory illness for a few days and tested positive on SARS-CoV-2 RT-PCR. Approximately 6 weeks later, he presents after 3 days of right-sided abdominal pain, diarrhoea and fever. He is initially admitted with a working diagnosis of gastroenteritis. Sustained fever and escalating blood markers of illness led to abdominal CT; showing inflammation of ascending colon as well as some loops of small bowel. Hypotension becomes increasingly pronounced and on the fourth day of admission he developed type 1 respiratory failure with evidence of fluid overload. He was transferred to critical care for vasopressor and respiratory support. All microbiological and autoimmune screens performed return negative results but inflammatory markers were significantly elevated, he was diagnosed as MIS-A. IVIg was added to the antibiotics on day 4. His clinical condition dramatically improved and he was discharged home after 10 days in hospital. His blood tests have returned to normal and he has no lasting complications from his illness.
DISCUSSION
CONCLUSIONS
This case displays the potential for MIS-A to present in various ways, with this example a primarily gastroenterological illness. It therefore highlights the importance of physicians in different fields having an awareness of the condition, in order to identify when MDT input is required to guide treatment. We review the current literature on various presentations and treatments of MIS-A, and discuss the need for clear case definition.
Identifiants
pubmed: 34458720
doi: 10.1016/j.clinpr.2021.100092
pii: S2590-1702(21)00029-7
pmc: PMC8379012
doi:
Types de publication
Case Reports
Langues
eng
Pagination
100092Informations de copyright
© 2021 The Authors.
Déclaration de conflit d'intérêts
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Références
Lancet Rheumatol. 2020 Oct;2(10):e594-e602
pubmed: 32864628
Arthritis Rheumatol. 2020 Nov;72(11):1791-1805
pubmed: 32705809
Circulation. 2020 Jun 9;141(23):1903-1914
pubmed: 32297796
Pediatrics. 2020 Dec;146(6):
pubmed: 32879033
Lancet Child Adolesc Health. 2021 Feb;5(2):133-141
pubmed: 32956615
MMWR Morb Mortal Wkly Rep. 2020 Oct 09;69(40):1450-1456
pubmed: 33031361
N Engl J Med. 2020 Jul 23;383(4):347-358
pubmed: 32598830
Chest. 2021 Feb;159(2):657-662
pubmed: 32910974
Circ Heart Fail. 2020 Oct;13(10):e007485
pubmed: 32844662
N Engl J Med. 2020 May 14;382(20):e60
pubmed: 32343504
Chest. 2021 Feb;159(2):471-472
pubmed: 33285106
Circulation. 2021 Jan 5;143(1):4-6
pubmed: 32787714
BMJ Case Rep. 2020 Sep 8;13(9):
pubmed: 32907870